Logo

American Heart Association

  46
  0


Final ID: MP478

Self-reported History of Heart Attack among Patients with Type 1 versus Type 2 Myocardial Infarction

Abstract Body (Do not enter title and authors here): Background:
The term “heart attack” is synonymous with myocardial infarction (MI). Epidemiologic studies that track MI incidence often rely on patient self-reported history of heart attack. We sought to compare patient self-reported history of heart attack shortly after a diagnosis of type 1 MI (T1MI) and type 2 MI (T2MI).
Methods:
In this single-center prospective cohort study, 150 consecutively eligible patients meeting strict Universal Definition of MI criteria for T1MI (n=75) and T2MI (n=75) were enrolled. Participants completed baseline (during their index MI hospitalization) and 1-month (4-6 weeks post-discharge) FRAIL scale questionnaires, including the question: “Did your doctor ever tell you that you have had a heart attack?” Multivariable logistic regression analysis evaluated the association between patient characteristics (age, sex, prior MI before the index MI, and presenting MI subtype) and self-reported history of heart attack.
Results:
149 baseline questionnaires and 92 1-month questionnaires were available at the time of this analysis, in which 108 participants (72%) self-reported a diagnosis of heart attack at either baseline or 1 month. Among all participants (n=149), individuals who were White (79.6% vs 61.0%, p=0.006) and who had a prior MI before their index MI (24.1% vs 7.3%, p=0.04) more commonly self-reported a heart attack. Patients with T2MI less commonly reported having had a heart attack shortly after their MI as compared to T1MI (54.7% vs 90.5%, p<0.001). Among individuals with T2MI (n=75), individuals with a prior MI before their index MI (31.7% vs 8.8%, p=0.03), higher peak high-sensitivity troponin concentrations (363 ng/L [IQR, 132, 673] vs 139 ng/L [73, 363], p=0.02), and those who underwent invasive coronary angiography (63.4% vs 29.4%, p=0.007) more often self-reported a heart attack. After adjusting for age, gender, race, and prior MI, T2MI patients were significantly less likely to report a history of heart attack than T1MI patients (odds ratio: 0.13 [95% CI, 0.04, 0.32]).
Conclusion:
Individuals who experienced a T2MI were almost 8 times less likely to report having had a heart attack shortly after their MI event as compared to those with T1MI. These results suggest that epidemiology studies that rely on self-reported history of heart attack may not accurately capture all MI subtypes. Further research is needed to better understand how clinicians communicate a diagnosis of T2MI and patients’ understanding of the diagnosis.
  • Luterstein, Elaine  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Kitzman, Dalane  ( Wake Forest University School of Medicine , Winston-Salem , North Carolina , United States )
  • Spertus, John  ( University of Missouri-Kansas City’s Healthcare Institute for Innovations in Quality and Saint Luke's Mid America Heart Institute , Kansas City , Missouri , United States )
  • Huffman, Jeff  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Natarajan, Pradeep  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Januzzi, James  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Mccarthy, Cian  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Tong, Nhi  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Murphy, Sean  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Raghavan, Avanthi  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Paquette, Charlotte  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Lin, Claire  ( Harvard Medical School , Boston , Massachusetts , United States )
  • Liu, Yuxi  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Wasfy, Jason  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Doros, Gheorghe  ( Boston University School of Public Health , Boston , Massachusetts , United States )
  • Author Disclosures:
    Elaine Luterstein: DO NOT have relevant financial relationships | Dalane Kitzman: No Answer | John Spertus: DO have relevant financial relationships ; Consultant:BioHaven, Janssen, Bristol Meyers Squibb, Terumo, Cytokinetics, BridgeBio, VentricHealth, and Imbria:Active (exists now) ; Executive Role:Blue Cross Blue Shield of Kansas City:Active (exists now) ; Royalties/Patent Beneficiary:SAQ, KCCQ, PAQ:Active (exists now) | Jeff Huffman: No Answer | Pradeep Natarajan: DO have relevant financial relationships ; Researcher:Amgen, Genentech / Roche:Active (exists now) ; Other (please indicate in the box next to the company name):Vertex Pharmaceuticals (spousal employment):Active (exists now) ; Ownership Interest:Bolt, Candela, Mercury, MyOme, Parameter Health, Preciseli, TenSixteen Bio:Active (exists now) ; Consultant:Allelica, CRISPR Therapeutics, Genentech/Roche, HeartFlow, Magnet Biomedicine:Past (completed) ; Consultant:AstraZeneca, Blackstone Life Sciences, Bristol Myers Squibb, Eli Lilly & Co, Esperion Therapeutics, Foresite Capital, Foresite Labs, GV, Merck, Novartis, Novo Nordisk, TenSixteen Bio, Tourmaline Bio:Active (exists now) ; Researcher:Allelica, Novartis:Past (completed) | James Januzzi: DO have relevant financial relationships ; Individual Stocks/Stock Options:Imbria:Active (exists now) ; Researcher:Celecor:Active (exists now) ; Consultant:Roche:Active (exists now) ; Consultant:Jana Care:Active (exists now) ; Consultant:Beckman:Active (exists now) ; Consultant:Abbott:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Researcher:BMS:Active (exists now) ; Researcher:AstraZeneca:Active (exists now) ; Researcher:Applied Therapeutics:Active (exists now) ; Researcher:Abbott:Active (exists now) ; Individual Stocks/Stock Options:Prevencio:Active (exists now) ; Individual Stocks/Stock Options:Fibrosys:Active (exists now) ; Individual Stocks/Stock Options:Jana Care:Active (exists now) | Cian McCarthy: DO have relevant financial relationships ; Consultant:HeartFlow:Active (exists now) ; Consultant:NewAmsterdam Pharma:Active (exists now) ; Consultant:Abbott Laboratories:Past (completed) ; Consultant:Roche Diagnostics:Active (exists now) | Nhi Tong: No Answer | Sean Murphy: DO NOT have relevant financial relationships | Avanthi Raghavan: DO NOT have relevant financial relationships | Charlotte Paquette: DO NOT have relevant financial relationships | Claire Lin: No Answer | Yuxi Liu: DO NOT have relevant financial relationships | Jason Wasfy: DO NOT have relevant financial relationships | Gheorghe Doros: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cracking the Code of Coronary Care: Timing, Trials, and Turning Points in Acute MI Management

Saturday, 11/08/2025 , 10:45AM - 11:55AM

Moderated Digital Poster Session

More abstracts on this topic:
A Meta-Analysis on the Effect of Chronic Total Occlusion of Coronary Arteries on Cardiovascular Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Goyal Aman, Tariq Muhammad Daoud, Zahra Rubab, Jain Hritvik, Khan Rozi, Mahalwar Gauranga

A Machine Learning Readmission Risk Prediction Model for Cardiac Disease

Bailey Angela, Wang Wei, Shannon Clarence, Huling Jared, Tignanelli Christopher

More abstracts from these authors:
Temporal Trends and Predictors of Cardiac Biomarker Testing in the Emergency Department, 2014-2021

Watson Nathan, Wasfy Jason, Baugh Christopher, Januzzi James, Secemsky Eric, Mccarthy Cian

Risk Scores and Hypertension Management

Mccarthy Cian

You have to be authorized to contact abstract author. Please, Login
Not Available